Enzon Pharmaceuticals, Inc.

Enzon Pharmaceuticals, Inc. Drugs

• Oncaspar
  

  ×

  Oncaspar

  

  ---

  2.1 Recommended Dose

  The recommended dose of Oncaspar® is 2,500 IU/m2 intramuscularly (IM) or intravenously (IV). Oncaspar® should be administered no more frequently than every 14 days.

  2.2 Instructions for Administration

  When Oncaspar® is administered IM, the volume at a single injection site should be limited to 2 mL. If the volume to be administered is greater than 2 mL, multiple injection sites should be used.

  When administered IV, Oncaspar® should be given over a period of 1 to 2 hours in 100 mL of sodium chloride or dextrose injection 5%, through an infusion that is already running.

  2.3 Preparation and Handling Precautions

  Do not administer Oncaspar® if drug has been:

  frozen stored at room temperature (+15°C to +25°C; 59°F to 77°F) for more than 48 hours shaken or vigorously agitated [see How Supplied/Storage and Handling (16)]

  Parenteral drug products should be inspected visually for particulate matter, cloudiness, or discoloration prior to administration, whenever solution and container permit. If any of these are present, discard the vial.

  Close
  More Info